Tranzactioneaza Aclaris Therapeutics Inc (US.ACRS) - 1.02 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 1.0100 USD
Ask 1.0200 USD
Minim 1.0200 USD
Maxim 1.0300 USD
Pret referinta 1.1700
Volum -
Volum ultima zi 1
Max 52 sapt -
Min 52 sapt -

Descriere companie

Aclaris Therapeutics, Inc. (https://www.aclaristx.com/) is a clinical-stage biopharmaceutical company. The Company is focused on developing drug candidates for immuno-inflammatory diseases. Its drug candidates include ATI-450, ATI-1777, ATI-2138 and Undisclosed- Gut Restricted Program. Its ATI-450 is an investigational oral, small molecule selective mitogen-activated protein kinase-activated protein kinase 2, or MK2, inhibitor compound, for the treatment of rheumatoid arthritis. Its ATI-1777 is an investigational topical soft-JAK inhibitor compound, for the treatment of atopic dermatitis. Its ATI-2138 is an investigational oral ITK/TXK/JAK3, or ITJ, inhibitor compound, as al treatment for psoriasis and/or inflammatory bowel disease, which are both T-cell mediated autoimmune diseases.

Informatii companie

Nume

Aclaris Therapeutics Inc